The American Urological Association (AUA) clinical guidelines define biochemical prostate specific antigen (PSA) recurrence (BCR) as PSA 0.2 ng/ml or greater. Ultrasensitive PSA (uPSA) assays, which can accurately measure PSA less than 0.1 ng/ml and often less than 0.01 ng/ml, are now available at most clinical laboratories. They are commonly used for monitoring men after prostatectomy. However, there are no guidelines as to how the ... read more
Should Clinicians Use Ultrasensitive Prostate Specific Antigen Measurements for Patient Evaluation?